POS7 COST-EFFECTIVENESS SIMULATION MODELING OF THE COMPLIANCE OF 5 MG ZOLEDRONIC ACID ONCE A YEAR VERSUS CURRENT TREATMENTS IN POST-MENOPAUSAL OSTEOPOROSIS
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65385-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65385-5/fulltext
Section Title :
Section Order :
544
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65385-5&doi=10.1016/S1098-3015(10)65385-5